by SXHH Marketing | Jul 3, 2026 | Hormone Replacement Therapy, Menopause
After many menopause awareness campaigns, Rhode Island has become the first state to introduce workplace protections specifically addressing menopause. This marks a major first step forward in how women’s health is recognized in professional environments.
For decades, menopause has been experienced by millions of working women while remaining unspoken when it came to workplace policy. Symptoms that can significantly affect daily life have been managed quietly, without acknowledgement or accommodation.
Rhode Island policy signals a shift. It opens the door for more conversations about how menopause impacts working women and what support can look like in the workplace.
Why Rhode Island’s Policy Matters
Despite its widespread impact, menopause has historically been missing from workplace policy.
Millions of women continue working full-time through perimenopause and menopause without support systems in place. Until recently, symptoms were often viewed as personal health concerns rather than factors that can affect job performance and workplace experiences.
Rhode Island’s policy recognizes menopause as a workplace health issue and encourages protections that support employees experiencing symptoms that may affect their work performance.
Rhode Island’s move brings more attention to inevitable life changes that have long existed in the background. It also reflects a growing awareness that women’s health deserves recognition in workplace planning, not just private management.
How Menopause Affects Work & Daily Life
Perimenopause and menopause are not just a single symptom. It is a collection of physical, emotional, and cognitive changes driven by shifting hormone levels.
These changes can vary widely from person to person, but many women experience overlapping symptoms that impact both daily life and work performance.
Symptoms of perimenopause and menopause include:
- Irregular menstrual cycles
- Mood swings
- Hot flashes
- Night sweats
- Sleep disturbances
These symptoms can translate into reduced concentration and lower energy levels that carries into the workday. For many women, this is often mistaken for stress, burnout, or aging rather than a hormonal transition.
Where Hormone Replacement Therapy (HRT) Comes In
Menopause primarily happens when your key hormones, estrogen, progesterone and in some cases, testosterone, begin to decline.
Hormone replacement therapy or HRT is a treatment option that may help support women experiencing the symptoms of perimenopause or menopause.
It is important to note that hormone replacement therapy is not a one-size-fits-all treatment. Treatment depends on you as an individual, which is why HerKare takes pride in personalization.
How HerKare Supports Women through Menopause
HerKare provides personalized hormone therapy designed to support women navigating perimenopause and menopause. Through comprehensive hormone testing, one-on-one provider consultations, and ongoing monitoring and treatment adjustments, care is built around each patient’s unique profile.
Menopause care is not just about managing symptoms. It’s about understanding how hormonal changes affect the whole person and creating a plan that evolves over time.
If menopause symptoms are affecting your energy, focus, sleep, and overall quality of life, you do not have to navigate those changes alone.
Schedule your consultation and take control of your hormone health today.
People Also Ask
Why is menopause becoming a workplace issue?
More women are pushing through symptoms of perimenopause and menopause in the workplace making symptom management an important workplace issue. Policies like Rhode Island’s reflect growing awareness of this impact.
Can HRT help with menopause symptoms at work?
Yes. HRT can help improve symptoms of menopause, which can indirectly improve focus and daily functioning at work.
What helps with menopause symptoms besides HRT?
Lifestyle changes like improving sleep habits, managing stress, and diet may bring some relief.
State of Rhode Island General Assembly
by SXHH Marketing | Jul 2, 2026 | Hormone Replacement Therapy, Menopause, Wellness
America is celebrating a milestone, and HerKare is celebrating it with you by offering $250 toward other services when you start testosterone replacement therapy (TRT).
Throughout the month of July, new patients who begin testosterone replacement therapy (TRT) through testosterone cypionate injections and remain on treatment for at least 90 days will receive $250 in account credit. No referral needed.
Now has never been a better time to know your baseline and find out whether low testosterone may be contributing to the way you feel. While testosterone is often thought of as a “man’s hormone”, it is just as important for women.
Testosterone Isn’t Just for Men
Women naturally produce testosterone in the ovaries. Although women have much lower levels than men, testosterone still plays an important role in overall health and wellbeing.
Healthy testosterone levels help support:
- Energy
- Sexual health
- Mood
- Mental clarity
- Bone health
- Recovery
- Overall quality of life
As women navigate life changes, especially perimenopause and menopause, testosterone levels decline naturally. For some women, this can lead to unwanted symptoms that disrupts everyday life.
Signs of Low Testosterone in Women
- Low libido
- Fatigue
- Brain fog
- Unexplained weight gain
- Thinning hair
- Irregular periods
- Low motivation
Why Personalized Care Matters
Every woman is different, and symptoms can vary widely from person to person.
TRT isn’t one-size-fits-all.
That’s why HerKare takes pride in individualized treatment plans, comprehensive lab testing, and ongoing provider support. Your care is tailored based on your hormone levels, symptoms, and how your body responds over time.
If treatment is recommended, HerKare uses pharmaceutical-grade testosterone cypionate injections and monitors your progress to help ensure treatment is safe and effective.
Discover the Benefits of Testosterone Therapy and Get $250
As part of our $250 for 250 celebration, eligible new patients who begin TRT in July and remain on treatment for at least 90 days will receive a $250 account credit to use toward future eligible HerKare services.
No referral is needed. Just start your TRT journey during this promotional period and continue your provider-led treatment plan.
Schedule your consultation with HerKare today to learn more about testosterone replacement therapy (TRT) for women and take advantage of this limited-time deal while the offer is still available!
Offer Details
Eligible patients must:
- Be a new HerKare patient beginning testosterone replacement therapy (TRT)
- Start testosterone cypionate injections between July 1st and July 31st, 2026
- Remain on treatment for at least 90 days
After meeting these requirements, patients will receive a $250 account credit applied to their account.
FAQs
When do I receive my $250 credit?
After you’ve remained on treatment for at least 90 days.
Who qualifies for the promotion?
New female patients who begin testosterone replacement therapy with testosterone cypionate injections between July 1st-31st, 2026.
Do I need a referral?
No. This promotion does not require a referral.
Can I receive cash instead?
No. The promotion provides a $250 account credit that may be used toward eligible HerKare services.
Can existing TRT patients participate?
No. This promotion is only available to new patients beginning TRT during the promotional period.
Terms & Conditions: Offer valid for new patients who begin testosterone replacement therapy (TRT) with testosterone cypionate injections between July 1 and July 31, 2026. Patients must remain on treatment for at least 90 days to qualify. Eligible patients will receive one (1) $250 account credit after completing the required treatment period. Credit is subject to the SynergenX Referral Credit Program Terms & Conditions, may be applied toward future eligible services, has no cash value, is non-transferable, expires one year from the date of issuance, and cannot be combined with other promotional account credit offers. Other restrictions may apply.
by SXHH Marketing | Jun 12, 2026 | Uncategorized
For over 12 years, women have trusted HerKare to help guide them through some of life’s biggest hormonal changes, from perimenopause to menopause to low energy, weight changes, mood shifts, and more.
Now, that care is evolving under one unified name: SynergenX.
Over the next year, HerKare clinics along with Low T Centers across the country will slowly transition to the SynergenX brand. While the name and look may change, our commitment to women’s wellness remains the same.
This transition reflects the continued growth of a company focused on helping you feel healthier, more confident, and like yourself again through personalized, medically guided care.
Since 2016, SynergenX has worked to create a more supportive and individualized approach when it comes to wellness. For many women, hormonal changes during perimenopause and menopause can affect nearly every part of daily life. And at SynergenX, care is made to address the full picture, not just a single symptom.
In addition to hormone therapy, SynergenX continues to expand services for women through medically guided weight management, wellness therapies, and ongoing support designed to help you feel your best at every stage of life.
Over the years, hundreds of thousands of women have trusted HerKare with their care. Many women find themselves at HerKare feeling exhausted and disconnected from the version of themselves they once knew. And these women leave feeling more balanced, energized, and confident in their health journey. For CEO Wayne Wilson, these experiences continue to drive the company’s mission forward:
“Helping patients feel like themselves again is one of the most meaningful things we can do in healthcare. This transition reflects who we are today and where we are going in the future. The SynergenX brand represents our commitment to personalized care, innovation, and helping patients become the healthiest, strongest versions of themselves.”
This transition to the SynergenX brand will happen slowly across clinic signage, websites, communications, and digital platforms over the coming year. If you are a patient, you can continue to expect the same providers, the same care teams, and the same compassionate approach to wellness throughout the process.
While the HerKare name is changing, our mission remains the same: Helping women feel balanced, supported, confident, and empowered in their health.
by SXHH Marketing | Feb 12, 2026 | Uncategorized
By Carolyn Moyers, D.O., FACOG
Are you taking, or considering, hormone replacement therapy (HRT) to treat bothersome menopause symptoms? How does this impact your heart health?
There has been controversy around hormone replacement therapy (HRT) over past decades. HRT has gone from a standard treatment for hot flashes and other symptoms of menopause to a decision each woman must weigh carefully based on her body and health history.
Some research has linked HRT to increased risk of heart disease, stroke, blood clots, and breast cancer, while other studies have shown hormone replacement may lower the risk of osteoporosis and improve other aspects of health.
Read the literature on this and your head will be spinning. Recent studies are showing benefits to women, particularly women who use HRT close to the onset of menopause, although, the duration of therapy and relationship to heart health awaits further study.
Hormone replacement therapy – estrogen, estrogen + progesterone, and dare you add testosterone – It’s all so confusing. “What are my risks?” patient’s often ask.
Risks in perspective
- The risk of heart disease to an individual woman taking hormone therapy is very low.
- Your individual risk of developing heart disease depends on many factors, including family medical history, personal medical history and lifestyle practices.
- If you stopped having periods or lost normal function of your ovaries before age 40, you have a different set of heart and blood vessel (cardiovascular) health risks compared with women who reach menopause near the average age of about 50. This includes a higher risk of coronary heart disease.
Talk to your provider about your personal risks. If you’re at low risk of heart disease, and your menopausal symptoms are significant, hormone therapy is a reasonable consideration.
HRT risks may vary depending on:
- Whether estrogen is given alone or with a progesterone
- Your current age and age at menopause
- The dose, type of estrogen and how you take it (oral, transdermal, transvaginal)
- Other health risks, such as your family medical history and cancer risks
Who should NOT take hormone therapy?
If you’ve already had a heart attack, HRT is not for you. If you already have heart disease or you have a history of blood clots, the risks of hormone therapy have been clearly shown to outweigh any potential benefits.
Menopause symptoms: What are they and why are women seeking treatment?
As women age, they find themselves with sudden sensation of extreme heat in the upper body, face, neck and chest, referred to as a hot flush. The unwelcome sweating, flushing, chills, clamminess, anxiety and even heart palpitations accompany this. These unwelcome vasomotor symptoms vary in how often and how long they last. Patients report symptoms lasting anywhere from 4-10 years around menopause. While menopause is defined as not having cycles for 12 months, symptoms do not end with the end of menstrual cycles. Sigh . . . The low estrogen levels leads to changes in the vagina– vaginal or vulvar dryness, discharge, itching and painful intercourse. The lack of estrogen leads to a loss of superficial epithelial cells, vaginal folds and elasticity and narrowing and shortening of the vagina. In addition, the pH of the vagina even changes and can lend to more urogenital infections. “Really?!” I hear you asking yourself. All these changes have women feeling frustrated, fatigued and often questioning their sanity.
HRT and the Heart
The consensus at this time is that menopausal hormone replacement therapy should not be used for the primary prevention of coronary heart disease. There is some data that supports a “timing hypothesis” – meaning, the cardiovascular benefit is most profound when HRT is used at the onset of menopause versus someone who has been menopausal 10 years or more. We do not know the affects of the duration of HRT at this time.
Your provider will likely recommend a heart healthy lifestyle to reduce your cardiovascular risks.
- Don’t smoke or use tobacco products.
- Get regular physical activity.
- Eat a healthy diet focusing on fruits, vegetables, whole grains and low-fat protein.
- Maintain a healthy weight.
- Get regular health screenings to check your blood pressure and cholesterol levels to detect early signs of heart disease.
We also understand that quality of life must be considered when prescribing HRT. Lifestyle changes and over the counter solutions don’t always provide the relief you so desperately desire. HRT must be individualized based on each woman’s risk-benefit ratio and clinical presentation.
How is HRT different at HerKare?
A customized treatment plan specific to each patient is designed to improve symptoms. The goal is to achieve a balance of hormones, vitamin deficiencies, and thyroid function.
A balancing act
Among U.S. women, nearly 1 in 4 deaths each year is due to heart and blood vessel (cardiovascular) disease. Women of all ages should take heart disease seriously.
Most healthy women can safely take HRT for menopausal symptoms without significantly increasing the risk of heart disease. If you experience classic menopausal symptoms talk to your provider about how you can relieve troublesome symptoms without putting your health at risk.
by SXHH Marketing | Dec 12, 2025 | Hormone Replacement Therapy, Menopause, Wellness
For years, menopausal hormone therapy carried a warning label that did more than flag risk. It shaped perception. It ended conversations before they started. For many women, it quietly reinforced the idea that relief came with a price that was simply too high.
The FDA has now removed the black box warning from certain menopausal hormone therapy products, and the significance of that change goes beyond labeling. It signals a long-overdue recalibration in how women’s hormone care is understood.
How we got here
The warning traces back to the Women’s Health Initiative studies published in the early 2000s. Those findings linked specific hormone therapies to increased risks of blood clots, stroke, and breast cancer in certain populations.
What mattered then, and still does, is context.
The study primarily examined older women, often more than a decade past menopause, and prescribed oral hormone formulations that reflected clinical norms of the time. The results were meaningful, but their application became sweeping. A single narrative took hold, flattening nuance and leaving little room for clinical judgment or individual variation.
Why the warning no longer made sense
Two decades later, menopausal hormone therapy looks fundamentally different.
Research has continued. Clinical practice has evolved. The conversation around timing, formulation, dosing, and patient selection has grown more precise. We now understand that hormone therapy initiated closer to menopause carries a different risk profile than therapy started years later. We understand that delivery method matters. We understand that cardiovascular and metabolic health cannot be separated from hormone decisions.
The FDA’s decision to remove the black box warning reflects this accumulation of knowledge. It acknowledges that the label no longer aligned with how menopausal hormone therapy is prescribed or evaluated today.
Why this matters to women now
The black box warning informed, but it also created fear in women who could have benefited from HRT.
For many women, it became shorthand for danger, reinforcing hesitation even as symptoms mounted. Brain fog. Disrupted sleep. A persistent sense of being off balance. Mood changes that felt unfamiliar. A body that no longer responded the way it once did.
The removal of the warning does not suggest that hormone therapy is universally appropriate. What it does is restore the possibility of discussion without fear of being the loudest voice in the room.
What has not changed
Hormone therapy remains a medical intervention that requires discernment.
Women considering menopausal hormone therapy should expect:
-
An individualized medical evaluation
-
Careful attention to health history and risk factors
-
Dosing that reflects both symptoms and physiology
-
Ongoing monitoring over time
The shift is not toward casual prescribing. It is toward care that reflects current science rather than outdated generalizations.
Where HerKare stands
At HerKare, menopausal hormone therapy is approached as a collaborative, patient-focused process. Care is shaped by how a woman feels, what her labs reveal, and how her health evolves.
